We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$131M
1-Year Est. Return
46.14%
This Fund
S&P 500
This Quarter
Est. Return
-4.32%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$80.2M
AUM Growth
-$12.3M
(-13%)
Cap. Flow
-$6.04M
Cap. Flow
% of AUM
-7.53%
Top 10 Holdings %
Top 10 Hldgs %
42.03%
Holding
68
New
5
Increased
10
Reduced
20
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regenxbio
RGNX
|
+$1.42M |
| 2 |
VRTU
Virtusa Corporation
VRTU
|
+$1.4M |
| 3 |
APTO
Aptose Biosciences, Inc.
APTO
|
+$1.26M |
| 4 |
CTLP
Cantaloupe
CTLP
|
+$934K |
| 5 |
CSSEP
Chicken Soup for the Soul Entertainment, Inc. Series A Cumulative Redeemable Perpetual Preferred Stock
CSSEP
|
+$748K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATTU
Attunity Ltd
ATTU
|
+$4.58M |
| 2 |
Amplify Alternative Harvest ETF
MJ
|
+$2.22M |
| 3 |
Kratos Defense & Security Solutions
KTOS
|
+$1.83M |
| 4 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$994K |
| 5 |
EverQuote
EVER
|
+$888K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.64% |
| 2 | Healthcare | 20.3% |
| 3 | Communication Services | 16.54% |
| 4 | Consumer Staples | 9.41% |
| 5 | Financials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Digital Turbine
APPS
$975M
| $4.71M | 5.87% |
730,000
-70,000
| -9% | -$435K |
|
|
VRTU
2
DELISTED
Virtusa Corporation
VRTU
| $3.96M | 4.94% |
110,000
+35,000
| +47% | +$1.4M |
|
3
Mitek Systems
MITK
$754M
| $3.86M | 4.81% |
400,000
+60,000
| +18% | +$598K |
|
|
CTLP
4
DELISTED
Cantaloupe
CTLP
| $3.59M | 4.48% |
490,000
+130,000
| +36% | +$934K |
|
5
Allot
ALLT
$372M
| $3.47M | 4.32% |
430,000
-75,000
| -15% | -$571K |
|
6
Magnite
MGNI
$2.76B
| $3.16M | 3.94% |
362,500
-37,500
| -9% | -$329K |
|
7
Marchex
MCHX
$76.2M
| $3.14M | 3.92% |
1,000,000
+15,003
| +2% | +$57.8K |
|
|
RCM
8
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.99M | 3.73% |
335,000
-15,000
| -4% | -$177K |
|
9
Ambarella
AMBA
$3.77B
| $2.51M | 3.13% |
40,000
| – | – |
|
|
10
Regenxbio
RGNX
$620M
| $2.31M | 2.89% |
65,000
+35,000
| +117% | +$1.42M |
|
11
Chegg
CHGG
$110M
| $2.25M | 2.8% |
75,000
| – | – |
|
12
CareCloud
CCLD
$104M
| $2.21M | 2.76% |
584,900
+134,900
| +30% | +$617K |
|
|
13
EverQuote
EVER
$892M
| $2.2M | 2.74% |
103,000
-47,000
| -31% | -$888K |
|
|
EIGR
14
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.05M | 2.56% |
6,667
| – | – |
|
15
uniQure
QURE
$3.03B
| $2.05M | 2.55% |
52,000
| – | – |
|
16
Gaia
GAIA
$46.8M
| $1.8M | 2.24% |
275,000
-25,000
| -8% | -$176K |
|
|
EMKR
17
DELISTED
Emcore Corp
EMKR
| $1.78M | 2.22% |
58,000
-2,000
| -3% | -$59.7K |
|
|
ASPU
18
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.56M | 1.94% |
300,000
| – | – |
|
|
QUOT
19
DELISTED
Quotient Technology Inc
QUOT
| $1.49M | 1.85% |
190,000
-60,000
| -24% | -$542K |
|
20
LendingTree
TREE
$447M
| $1.24M | 1.55% |
4,000
| – | – |
|
|
MNDT
21
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.2M | 1.5% |
90,000
-70,000
| -44% | -$994K |
|
22
Varonis Systems
VRNS
$4.59B
| $1.2M | 1.49% |
60,000
| – | – |
|
|
RETA
23
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.12M | 1.4% |
14,000
-1,000
| -7% | -$84.9K |
|
|
APTO
24
DELISTED
Aptose Biosciences, Inc.
APTO
| $1.04M | 1.3% |
+1,111
| New | +$1.26M |
|
|
CNST
25
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.03M | 1.29% |
160,000
+40,000
| +33% | +$334K |
|
Similar funds
EIM
CIP
AC
ADEF
LC
EWP
OIM
EPI
P.A.W. Capital's Q3 2019 Portfolio in Review
As of Q3 2019, P.A.W. Capital held 68 positions worth $80.2M, down 13% from $92.5M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
P.A.W. Capital withdrew a net $6.04M in Q3 2019, closing 7 positions and reducing 20 holdings. Its most notable exit was Attunity Ltd, an estimated $4.58M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, P.A.W. Capital opened a new position in Aptose Biosciences, Inc. worth $1.04M.
- P.A.W. Capital's largest Q3 2019 buy was Aptose Biosciences, Inc.: 1,111 shares worth $1.04M.
- P.A.W. Capital added most to Regenxbio in Q3 2019, an estimated $1.42M increase.
- P.A.W. Capital's biggest Q3 2019 reduction was Mandiant, Inc. Common Stock, cutting an estimated $994K.
- P.A.W. Capital fully exited Attunity Ltd in Q3 2019, selling an estimated $4.58M.
- P.A.W. Capital's ten largest holdings make up 42% of its $80.2M portfolio in Q3 2019.
- P.A.W. Capital opened 5 new positions and closed 7 in Q3 2019.
- P.A.W. Capital's portfolio value fell 13% quarter-over-quarter to $80.2M.
Based on P.A.W. Capital's 13F filing for Q3 2019, filed 30 Oct 2019.